News from regado biosciences, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 29, 2013, 16:57 ET

Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering

Regado Biosciences, Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission...

Dec 19, 2012, 09:00 ET

Regado Biosciences, Inc. Secures $51 Million Series E Financing

 Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced it...

Dec 05, 2012, 10:17 ET

Regado Biosciences, Inc. to Present at the Oppenheimer 23rd Annual Healthcare Conference in New York, NY

 Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced...

Sep 12, 2012, 10:17 ET

Regado Biosciences, Inc. to Present at the UBS Global Life Sciences Conference 2012 in New York, NY

Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that...

Aug 29, 2012, 10:17 ET

Regado Biosciences, Inc. to Present at the Stifel Nicolaus Healthcare Conference 2012 in Boston, MA

Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that...

Aug 08, 2012, 10:17 ET

Regado Biosciences, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference in Boston, MA

 Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced...

Aug 07, 2012, 10:17 ET

Regado Biosciences, Inc. to Present at the 2012 Wedbush PacGrow Life Sciences Conference in New York, NY

 Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced...

Mar 28, 2012, 10:17 ET

Regado Biosciences, Inc. to Present at Needham & Company's 11th Annual Healthcare Conference in New York, NY

 Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced...

Mar 14, 2012, 10:17 ET

Regado Biosciences, Inc. to Present at the BIO-Europe Spring® 2012 Conference in Amsterdam, The Netherlands

 Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced...

Feb 28, 2012, 11:59 ET

Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA

Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that...

Feb 22, 2012, 10:17 ET

Regado Biosciences, Inc. to Present at the Citi 2012 Global Health Care Conference in New York, NY

Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that...

Nov 14, 2011, 15:02 ET
Nov 07, 2011, 11:02 ET

Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System at the Transcatheter Cardiovascular Therapeutics (TCT) Symposium 2011

Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced the...

Sep 28, 2011, 10:17 ET

Regado Biosciences, Inc. to Present at the Sofinnova Japan Biopharma Partnering Conference in Tokyo, Japan

Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced that...

Sep 14, 2011, 10:17 ET

Regado Biosciences to Present at the Annual UBS Global Life Sciences Conference in New York City

Regado Biosciences, a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced that Ellen...

Apr 03, 2011, 14:15 ET

Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System

Regado Biosciences, Inc., a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced...

Mar 30, 2011, 10:17 ET

Regado Biosciences to Present at the Needham & Company's 10th Annual Healthcare Conference in New York City

Regado Biosciences, a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced that David...

Mar 28, 2011, 12:09 ET
Feb 23, 2011, 10:17 ET

Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City

Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Ellen...

Nov 23, 2010, 10:17 ET

Regado Biosciences to Present at the 22nd Annual Piper Jaffray Health Care Conference in New York City and the Canaccord Genuity 5th Annual Cardiovascular, Diabetes & Obesity Conference in San Francisco

Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that David J....